Initial experience of single-incision robotic surgery for lateral suspension of patients with pelvic organ prolapse

Abstract

Objective

The aim of this study was to describe technical considerations and short-term outcomes from the first reported eight cases of single-incision robotic operation for lateral suspension of patients with pelvic organ prolapse using the SHURUI robotics surgical system (SR-ENS-600, SHURAI compony, Beijing Daxing Biomedical Base).

Methods

Eight patients with a body-mass index vary from 20 to 30 ​kg/m² was treated for anterior vaginal prolapse and apical prolapse by single-incision robot-assisted lateral suspension with the SHURUI robotics surgical system between March 2024 and June 2024 in Peking University People's Hospital.

Results

The single-incision SHURUI robot-assisted lateral suspension was successfully performed with eight patients who suffered from anterior vaginal prolapse and apical prolapse. The console time among the operation ranged from 192 ​min to 274 ​min, with intraoperative blood loss ranging from 20 ​mL to 100 ​mL. There was no urinary retention after urinary catheter removal. During the postoperative period, no severe adverse events occurred. There was no prolapse recurrence after one month of postoperative follow-up.

Conclusion

Single-incision SHURUI robot-assisted lateral suspension was a safe and feasible surgical method for patients with anterior vaginal prolapse and apical prolapse. The study provided a basis for subsequent research and highlighted the need for further clinical trials to verify its superior operative outcomes.